| Product Code: ETC10797189 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Pharmacogenomics Technology Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Pharmacogenomics Technology Market Revenues & Volume, 2021 & 2031F |
3.3 China Pharmacogenomics Technology Market - Industry Life Cycle |
3.4 China Pharmacogenomics Technology Market - Porter's Five Forces |
3.5 China Pharmacogenomics Technology Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 China Pharmacogenomics Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China Pharmacogenomics Technology Market Revenues & Volume Share, By Testing Method, 2021 & 2031F |
3.8 China Pharmacogenomics Technology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 China Pharmacogenomics Technology Market Revenues & Volume Share, By Market Driver, 2021 & 2031F |
3.9.1 Increasing focus on personalized medicine in China |
3.9.2 Government support and investments in healthcare infrastructure |
3.9.3 Growing prevalence of chronic diseases in the Chinese population |
4 China Pharmacogenomics Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
4.3.1 Lack of awareness and understanding of pharmacogenomics technology among healthcare professionals |
4.3.2 High costs associated with implementing pharmacogenomics technology |
4.3.3 Regulatory challenges and uncertainties in the Chinese healthcare system |
5 China Pharmacogenomics Technology Market Trends |
6 China Pharmacogenomics Technology Market, By Types |
6.1 China Pharmacogenomics Technology Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 China Pharmacogenomics Technology Market Revenues & Volume, By Technology Type, 2021 - 2031F |
6.1.3 China Pharmacogenomics Technology Market Revenues & Volume, By Genotyping, 2021 - 2031F |
6.1.4 China Pharmacogenomics Technology Market Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031F |
6.1.5 China Pharmacogenomics Technology Market Revenues & Volume, By Gene Expression Profiling, 2021 - 2031F |
6.1.6 China Pharmacogenomics Technology Market Revenues & Volume, By Bioinformatics Solutions, 2021 - 2031F |
6.1.7 China Pharmacogenomics Technology Market Revenues & Volume, By Companion Diagnostics, 2021 - 2031F |
6.2 China Pharmacogenomics Technology Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Pharmacogenomics Technology Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.2.3 China Pharmacogenomics Technology Market Revenues & Volume, By Drug Response Analysis, 2021 - 2031F |
6.2.4 China Pharmacogenomics Technology Market Revenues & Volume, By Oncology Treatment, 2021 - 2031F |
6.2.5 China Pharmacogenomics Technology Market Revenues & Volume, By Adverse Drug Reactions, 2021 - 2031F |
6.2.6 China Pharmacogenomics Technology Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
6.3 China Pharmacogenomics Technology Market, By Testing Method |
6.3.1 Overview and Analysis |
6.3.2 China Pharmacogenomics Technology Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.3.3 China Pharmacogenomics Technology Market Revenues & Volume, By Microarray, 2021 - 2031F |
6.3.4 China Pharmacogenomics Technology Market Revenues & Volume, By Whole Genome Sequencing, 2021 - 2031F |
6.3.5 China Pharmacogenomics Technology Market Revenues & Volume, By AI-Based Analytics, 2021 - 2031F |
6.3.6 China Pharmacogenomics Technology Market Revenues & Volume, By DNA Microarray, 2021 - 2031F |
6.4 China Pharmacogenomics Technology Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 China Pharmacogenomics Technology Market Revenues & Volume, By Pharma Companies, 2021 - 2031F |
6.4.3 China Pharmacogenomics Technology Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.4 China Pharmacogenomics Technology Market Revenues & Volume, By Research Labs, 2021 - 2031F |
6.4.5 China Pharmacogenomics Technology Market Revenues & Volume, By Academic Institutions, 2021 - 2031F |
6.4.6 China Pharmacogenomics Technology Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5 China Pharmacogenomics Technology Market, By Market Driver |
6.5.1 Overview and Analysis |
6.5.2 China Pharmacogenomics Technology Market Revenues & Volume, By Advancements in Precision Medicine, 2021 - 2031F |
6.5.3 China Pharmacogenomics Technology Market Revenues & Volume, By Increase in Genetic Testing, 2021 - 2031F |
6.5.4 China Pharmacogenomics Technology Market Revenues & Volume, By Growing Interest in Targeted Therapy, 2021 - 2031F |
6.5.5 China Pharmacogenomics Technology Market Revenues & Volume, By Expansion in Pharmacovigilance, 2021 - 2031F |
6.5.6 China Pharmacogenomics Technology Market Revenues & Volume, By Demand for Tailored Therapeutics, 2021 - 2031F |
7 China Pharmacogenomics Technology Market Import-Export Trade Statistics |
7.1 China Pharmacogenomics Technology Market Export to Major Countries |
7.2 China Pharmacogenomics Technology Market Imports from Major Countries |
8 China Pharmacogenomics Technology Market Key Performance Indicators |
8.1 Number of research collaborations between pharmaceutical companies and academic institutions in China |
8.2 Adoption rate of pharmacogenomics testing in major hospitals and healthcare facilities |
8.3 Number of pharmacogenomics-related research publications from Chinese researchers |
8.4 Percentage of healthcare professionals trained in pharmacogenomics technology in China |
8.5 Investment trends in pharmacogenomics technology startups in China |
9 China Pharmacogenomics Technology Market - Opportunity Assessment |
9.1 China Pharmacogenomics Technology Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 China Pharmacogenomics Technology Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China Pharmacogenomics Technology Market Opportunity Assessment, By Testing Method, 2021 & 2031F |
9.4 China Pharmacogenomics Technology Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 China Pharmacogenomics Technology Market Opportunity Assessment, By Market Driver, 2021 & 2031F |
10 China Pharmacogenomics Technology Market - Competitive Landscape |
10.1 China Pharmacogenomics Technology Market Revenue Share, By Companies, 2024 |
10.2 China Pharmacogenomics Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here